Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypersensitivities

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...

Allergic Reactions

Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...

Cross-reactivity

Cross-reactivity

Allergic Reactions: Anaphylaxis

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...

Antigens Involved in Adaptive Immunity

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Sarcoplasmic reticulum and calcium signaling in muscle cells: Homeostasis and disease.

International review of cell and molecular biology·2020

Same author

A histomorphometric classification system for normal and inflamed mouse duodenum-Quali-quantitative approach.

International journal of experimental pathology·2018

Same author

Herpud1 negatively regulates pathological cardiac hypertrophy by inducing IP3 receptor degradation.

Scientific reports·2017

Same author

Seroreactivity to <i>Anisakis</i> spp. in the perinatal period.

Obstetric medicine·2017

Same author

Subchronic toxicity and anti-HSV-1 activity in experimental animal of dolabelladienetriol from the seaweed, Dictyota pfaffii.

Regulatory toxicology and pharmacology : RTP·2017

Same author

Novel Therapies Targeting Cardioprotection and Regeneration.

Current pharmaceutical design·2017

Search research articles

Related Experiment Video

Updated: Jun 24, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Food allergy/hypersensitivity: antigenicity or timing?

Patrícia Olaya Paschoal¹, Sylvia M N Campos, Monique M B Pedruzzi

¹Programa de Pós-Graduação em Patologia, Faculdade de Medicina, Universidade Federal Fluminense, Brazil. popascoal@yahoo.com.br

|March 31, 2009

Summary

Introducing a new protein during gut inflammation, not its type, dictates immune response. Early oral ovalbumin (OVA) exposure before a challenge diet (CD) induced tolerance, while later exposure amplified antibody titers, highlighting timing in oral tolerance (OT) induction.

More Related Videos

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

Related Experiment Videos

Last Updated: Jun 24, 2026

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Antigenic Liposomes for Generation of Disease-specific Antibodies

Antigenic Liposomes for Generation of Disease-specific Antibodies

Published on: October 25, 2018

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Mouse Body Temperature Measurement Using Infrared Thermometer During Passive Systemic Anaphylaxis and Food Allergy Evaluation

Published on: September 14, 2018

Area of Science:

Immunology
Gastroenterology
Allergy Research

Background:

Oral tolerance (OT) and oral immunization mechanisms remain unclear.
Previous studies show peanut feeding induces tolerance in normal mice but gut inflammation in immunized mice.
This study investigates introducing new proteins into diets of animals with existing antigen-specific gut inflammation.

Purpose of the Study:

To evaluate the impact of introducing a novel protein (ovalbumin - OVA) on animals with pre-existing antigen-specific gut inflammation.
To determine if the timing of novel protein introduction influences immune response (tolerance vs. immunization).

Main Methods:

Adult female C57BL/6J mice were immunized with peanut protein extract.
Experimental groups were fed ovalbumin (OVA) at different time points relative to a 30-day peanut challenge diet (CD).
Systemic antibody (Ab) titers were measured to assess immune response.

Main Results:

Oral OVA exposure before the CD (in the absence of gut inflammation) resulted in low systemic Ab titers, similar to oral tolerance.
Introducing OVA after the onset of gut inflammation led to progressively higher systemic Ab titers, resembling immune responses.
The timing of OVA introduction was critical in determining the immune outcome.

Conclusions:

The timing of novel protein introduction is more critical than its antigenicity in influencing immune responses during gut inflammation.
Early dietary exposure to a new antigen can promote tolerance even in the presence of existing gut inflammation.
This suggests a window of opportunity for therapeutic interventions to induce oral tolerance.